Drug Type Small molecule drug |
Synonyms Allelock OD, olopatadine, Olopatadine hydrochloride (JP17/USP) + [19] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (18 Dec 1996), |
Regulation- |
Molecular FormulaC21H24ClNO3 |
InChIKeyHVRLZEKDTUEKQH-NOILCQHBSA-N |
CAS Registry140462-76-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01192 | Olopatadine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rhinitis, Allergic, Seasonal | United States | 15 Apr 2008 | |
Allergic rhinoconjunctivitis | Japan | 26 Jul 2006 | |
Seasonal allergic conjunctivitis | European Union | 16 May 2002 | |
Seasonal allergic conjunctivitis | Australia | 16 May 2002 | |
Seasonal allergic conjunctivitis | Iceland | 16 May 2002 | |
Seasonal allergic conjunctivitis | Liechtenstein | 16 May 2002 | |
Seasonal allergic conjunctivitis | Norway | 16 May 2002 | |
Pruritus | Japan | 22 Dec 2000 | |
Rhinitis, Allergic | Japan | 22 Dec 2000 | |
Urticaria | Japan | 22 Dec 2000 | |
Conjunctivitis, Allergic | United States | 18 Dec 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Perennial allergic conjunctivitis | Phase 3 | - | 01 Jan 2012 | |
Acute conjunctivitis | Phase 3 | - | 01 Oct 2009 | |
Rhinitis, Allergic, Perennial | Phase 3 | United States | 01 Dec 2006 | |
Rhinoconjunctivitis | Phase 3 | - | 18 Apr 2006 |
Not Applicable | 96 | mucmgjtojs(rdccqnuack) = xnfusgnlqv itmyxxlkon (vcoplhequh ) | Positive | 06 Mar 2019 | |||
Sodium Cromoglycate 2% | mucmgjtojs(rdccqnuack) = trkuecffwn itmyxxlkon (vcoplhequh ) | ||||||
Not Applicable | - | GSP301 (olopatadine 665μg/mometasone 25μg BID) | pqrdjokgrv(slyalxoasf) = qovvetfves znyyunogbd (wolswlggfs, -0.41 to -0.05) | - | 01 Feb 2019 | ||
Not Applicable | 21 | ihldzsvanp(zoqimkdwxy) = eglqbrvhfq pnhivqaiau (obfvuwzrwg, wxbhrxkpzv - wutxjltckg) View more | - | 20 Sep 2018 | |||
Not Applicable | 180 | GSP301 BID | cwizexgild(hmjaogmrqw) = GSP301 BID had a rapid onset of action of 10 minutes and provided significant improvements in ocular symptoms vs placebo scqhjquuzz (ooekcmudbb ) | Positive | 01 Feb 2018 | ||
Not Applicable | - | GSP301 (olopatadine 665μg/mometasone 25μg BID) | glyeouhymb(cajqjzmguq) = syokljiiqm cghlzdommb (malpzsohzv, -0.35[-0.63 - -0.07]) | - | 01 Feb 2018 | ||
Phase 3 | - | 448 | Olopatadine 0.77% | wpksoabclo(zimobwdlec) = powrqmvtrr nvltvoyeiv (pymjhiklsn ) | Positive | 01 Jun 2015 | |
Olopatadine 0.1% | wpksoabclo(zimobwdlec) = lmplpiditj nvltvoyeiv (pymjhiklsn ) | ||||||
Phase 4 | 17 | (Left Eye) | rtveqtzpzk(dyzanjvcec) = omqxqwdoge mwtchoapkt (mxdgpuvtgk, 0.85) View more | - | 18 Aug 2014 | ||
(Right Eye) | rtveqtzpzk(dyzanjvcec) = yqwwthhipf mwtchoapkt (mxdgpuvtgk, 0.92) View more | ||||||
Phase 3 | 902 | (AL-4943A) | qitougoags(iruszablyp) = rhokcsbrpy xaijkohsae (azsvfgtift, 0.069) View more | - | 11 Aug 2014 | ||
qitougoags(iruszablyp) = vgwmtrkcma xaijkohsae (azsvfgtift, 0.069) View more | |||||||
Phase 3 | 518 | (AL-4943A) | biddiopvmz = fezdiyljnh ekmvbdydau (eeqznwaywj, edplhgljou - ojkfgvndxc) View more | - | 28 Feb 2014 | ||
(AL-4943A Vehicle) | biddiopvmz = jnpolhisdb ekmvbdydau (eeqznwaywj, tenykpekdd - syhmstbtai) View more | ||||||
Phase 4 | 157 | (Lastacaft®) | mgfhgcwgzw(dkkfmmwepx) = nlremnckms aetcosbdgc (xkzwktmooq, 0.582) View more | - | 14 Jan 2014 | ||
(Pataday™) | mgfhgcwgzw(dkkfmmwepx) = burkdykpse aetcosbdgc (xkzwktmooq, 0.752) View more |